A year ago, West Texas Intermediate (WTI) was trading at $91.35 a barrel (bbl), while Brent crude was $110.35/bbl. That $19/bbl spread was a boon for oil refiners who could buy crude oil at prices based on WTI and sell finished products at prices tied to Brent. It was also a boon to railroads whose customers were happy to pay $10-$15/bbl to have oil shipped from North Dakota to the East or West Coast, where the delivered cost was still lower than for waterborne crudes like Brent.
Today WTI is trading at $103.38/bbl and Brent is at $108.85, for a Brent-WTI differential of $5.47/bbl. At that level, the windfall that refiners were enjoying a year ago is gone, and it is no longer economical to rail crude oil across the country. So the lower differential hurts both refiners and the railroads.
Top 10 Specialty Retail Companies To Watch For 2015: Jinzanghuang Tibet Pharmaceuticals Inc (JZHG)
Jinzanghuang Tibet Pharmaceuticals, Inc. distributes Tibetan pharmaceutical and nutraceutical products in the People�� Republic of China (PRC) through Leling Jinzanghuang Biotech Co., Ltd. (Leling JZH). The Company, through its wholly owned subsidiary, Tibet Medicine, Inc., owns 100% of Beijing Taibodekang Consulting Co., Ltd. (Beijing Taibodekang), a wholly foreign owned entity. Beijing Taibodekang had entered into four agreements with Leling Jinzanghuang Biotech Co., Ltd. (Leling Jinzanghuang) and with the equity owners in Leling Jinzanghuang. Collectively, the agreements provide Beijing Taibodekang exclusive control over the business of Leling Jinzanghuang. Leling Jinzanghuang engages in the distribution of the pharmaceutical and nutraceutical products that Tibetans have used for centuries to treat diseases and facilitate health. The distributed products are classified by Leling Jinzanghuang in three major categories: pharmaceuticals, therapeutic supplements, and dietary supplements.
The 13 Tibetan health products that Leling Jinzanghuang distributes are among those Tibetan medicines made with modern drug manufacturing techniques. The manufacturing equipment and techniques used by its supplier are certified under China�� national standards of Good Manufacturing Practice (GMP), and are in compliance with applicable regulations of the Chinese Food and Drug Administration (SFDA), which regulates both the pharmaceutical and the nutraceutical industries in China.
Ying Huang Tablet
Ying Huang Tablet is one the two pharmaceutical products marketed by Leling Jinzanghuang that been approved by SFDA. The effective ingredients in the Ying Huang Tablet are extracts from the honeysuckle and the Huangqin herb. It can be used to treat upper respiratory infections including pharyngitis, encephalitis and conjunctivitis. It can also be used to reduce inflammation and relieve pain.
San Qi Capsules
San Qi Capsules is a dietary supplements certified! by SFDA. San Qi Capsules lower blood lipid and cholesterol levels. Thus they can be used as a precautionary therapy to prevent cardiovascular diseases, including coronary heart disease, heart angina and stroke. In addition, the San Qi Capsules enhance immune system functions, which may help in the prevention of cancer.
Foshou Capsules
Foshou Capsules is a Tibetan nutraceutical. The effective ingredients, Xue Yu, Dongchong Xiacao, Fozhang, and Ginseng, are extracts of several plants and animals that are native to the Tibet Plateau.
Bai He Capsules
Bai He Capsules is a Tibetan dietary supplement. The effective ingredients consist of Baihe, Fozhang Ginseng and Himalayan purple jasmine. The Bai He Capsules are used to treat male erectile dysfunction and other sexual dysfunction problems.
The Company competes with Jingqiu Tibetan Medicine, Jinhe Tibetan Medicine and Tibetan Pharmaceutical Factory, Tibet Cheezheng Tibetan Medicine and Niemula Tibet Medicine.
Advisors' Opinion:- [By Peter Graham]
Small cap medical technology stock Sanomedics International Holdings (OTCMKTS: SIMH) recently completed financing and an acquisition while JinZangHuang Tibet Pharmaceuticals, Inc (OTCMKTS: JZHG) surged 48.28% on Friday. However, that�� only part of the story as one of these stocks has been the subject of paid promotions while the other has no new news for investors. So are either of these small cap stocks the cure for any portfolio pains you may be suffering from? Here is a quick reality check:
Top Railroad Stocks For 2014: Ophthotech Corp (OPHT)
Ophthotech Corporation, incorporated on January 05, 2007, is a biopharmaceutical company specializing in the development of therapeutics to treat diseases of the eye. The Company�� advanced product candidate is Fovista, which the Company is developing for use in combination with anti-VEGF drugs that represent the current standard of care for the treatment of wet age-related macular degeneration (wet AMD). Wet AMD is a serious disease of the central portion of the retina, known as the macula, which is responsible for detailed central vision and color perception. It is characterized by abnormal new blood vessel formation and growth, referred to as neovascularization, which results in blood vessel leakage, retinal distortion and scar formation. If untreated, the progressive retinal damage results in rapid, irreversible and severe vision loss. Wet AMD is the cause of blindness in patients over the age of 55 in the United States and the European Union.
The anti-VEGF market for the treatment of wet AMD consists predominantly of two drugs that are approved for marketing and primarily prescribed for the treatment of wet AMD, Lucentis and Eylea, and off-label use of the cancer therapy Avastin. The use of anti-VEGF drugs has significantly improved visual outcomes for patients with wet AMD who have been treated with these drugs as compared to untreated patients.
Advisors' Opinion:- [By John Udovich]
Yesterday, small cap biotech Acceleron Pharma Inc (NASDAQ: XLRN) rose 9.76%�plus shares are up 183.6% for retail investors since its September IPO, meaning its worth taking a closer look at the stock along with the performance of other biotech IPOs like BIND Therapeutics Inc (NASDAQ: BIND), Ophthotech Corp (NASDAQ: OPHT) and Foundation Medicine Inc (NASDAQ: FMI) which also debuted at the same time.
- [By John Udovich]
If you have not been watching the biotech sector lately, you should start paying attention as the sector along with small cap biotech stocks like Cell Therapeutics Inc (NASDAQ: CTIC), BIND Therapeutics Inc (NASDAQ: BIND) and TNI BioTech (OTCMKTS: TNIB) continue to produce a steady stream of good news for investors thanks to positive industry trends. Moreover, Ophthotech Corp (NASDAQ: OPHT), Foundation Medicine Inc (NASDAQ: FMI), Evoke Pharma and Fate Therapeutics Inc (NASDAQ: FATE) are this week's biotech IPOs that will no doubt be watched closely by Wall Street and industry observers in general. With that in mind, consider the following biotech news or recent articles about the industry and the small cap players in it:
- [By Jake L'Ecuyer]
Shares of Ophthotech (NASDAQ: OPHT) got a boost, shooting up 25.78 percent to $39.54 after the company reported that it has entered into an ex-US licensing and commercialization deal with Novartis Pharmaceuticals.
Top Railroad Stocks For 2014: Collectors Universe Inc. (CLCT)
Collectors Universe, Inc. provides authentication and grading services to dealers and collectors of high-value coins, trading cards, event tickets, autographs, memorabilia, and stamps in the United States. It offers authentication and grading services for coins under the Professional Coin Grading Service brand name; sports and trading cards under the Professional Sports Authenticator (PSA) brand name; vintage autographs and memorabilia under the PSA/DNA authentication services brand name; and stamps under the Professional Stamp Experts brand name. The company also publishes authoritative price guides, rarity reports, and other collectibles data to provide collectors with information. In addition, it operates the Certified Coin Exchange business-to-business Website, certifiedcoinexchange.com, where dealers can sell and purchase certified coins and other certified collectibles; and Collectors Corner Business-to-Consumer Website, collectorscorner.com, a business-to-consumer W ebsite where consumers can visit, identify, search, sort over, and select for purchase coins, trading cards, and items of currency that are certified by the company, as well as Collectors Clubs for coin, currency, and trading card collectors; and manages and operates collectibles trade shows and conventions. The company provides its services to dealers, collectors, and retail buyers and sellers of collectibles. Collectors Universe, Inc. was founded in 1986 and is headquartered in Santa Ana, California.
Advisors' Opinion:- [By Jeff Hwang]
Such multiple expansion may be a natural product of time (i.e., older cards naturally carry larger premiums over time), or more likely a combination of time and the card removal effect. That is, over time, the best examples of a given card get graded by Beckett Grading Services or Professional Sports Authenticator (PSA), a division of Collectors Universe (NASDAQ: CLCT ) , and are thus removed from the pool of ungraded cards; as a consequence, the value of ungraded cards declines in relation to the value of graded cards (or the value of graded cards rises in relation to ungraded cards), resulting in multiple expansion.
Top Railroad Stocks For 2014: Prestige Brand Holdings Inc.(PBH)
Prestige Brands Holdings, Inc., together with its subsidiaries, engages in marketing, selling, and distributing over-the-counter healthcare and household cleaning products primarily in North America. The company?s Over-The-Counter Healthcare segment offers a portfolio of OTC products under nine core OTC brands, including Chloraseptic sore throat remedies, Clear Eyes eye drops, Compound W wart removers, Dramamine motion sickness products, Efferdent and Effergrip denture products, Little Remedies pediatric healthcare products, Luden's cough drops, PediaCare pediatric healthcare products, and The Doctor?s brand of oral care products. This segment also provides other significant brands that include Dermoplast first-aid products, Murine eye and ear care products, NasalCrom allergy relief product, New-Skin liquid bandage, and Wartner wart removers. Its Household Cleaning segment markets household cleaning products, such as abrasive and non-abrasive tub and tile cleaner, scrubb ing pads and sponges, dilutables, anti-bacterial hard surface spray for counter tops, and glass cleaners under the Comet, Chore Boy, and Spic and Span brands. Prestige Brands Holdings distributes its products through various retail channels, including drug, food, dollar, and club stores, as well as supermarkets and mass merchandisers. The company was founded in 1996 and is headquartered in Irvington, New York.
Advisors' Opinion:- [By Eric Volkman]
Prestige Brands (NYSE: PBH ) is reaching to the other side of the world for its latest acquisition. The company announced that it has purchased the privately held Care Pharmaceuticals, based in New South Wales, Australia. The terms of the deal were not disclosed, although Prestige Brands did admit that it would be funded by monies drawn from an existing credit facility combined with cash on hand.
- [By Sean Williams]
What: Shares of Prestige Brands (NYSE: PBH ) , a marketer of over-the-counter health care and household cleaning products, jumped as much as 14% after it announced the acquisition of Australia's Care Pharmaceuticals.
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Prestige Brands Holdings (NYSE: PBH ) , whose recent revenue and earnings are plotted below.
No comments:
Post a Comment